The National Economic Burden of Rare Disease Study – 2021

This study aims to provide the most comprehensive assessment of the total burden of rare disease to date, including filling the knowledge gap in some of the less well-understood cost components (such as productivity loss in both the labor market as well as in social life) and caregiver economic burden.